Key facts
- This page summarizes Conroy Kevin T.'s Form 4 filing for SomaLogic, Inc..
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Sep 2021, 20:29.
Conroy Kevin T. - 01 Sep 2021 Form 4 Insider Report for SomaLogic, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Sep 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Sep 2021, 20:29:11 UTC
- Prior SEC filing
- 04 Aug 2021
- Next SEC filing
- 01 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Emes, Attorney-in-Fact for Kevin Conroy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Conroy Kevin T. filed Form 4 for SomaLogic, Inc. on 03 Sep 2021.
Change
- Previous filing in this sequence was filed on 04 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLGC
transaction
Class A Common Stock
Other
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 01 Sep 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SLGC
transaction
Derivative
Warrants to purchase Class A Common Stock (right to buy)
Award
- Transaction value
- Shares
- +166,666
- Change %
- Price
- Shares after
- 166,666
- Date
- 01 Sep 2021
- Ownership
- By Conroy Family Foundation, Inc.
- Underlying class
- Class A Common Stock
- Underlying amount
- 166,666
- Exercise price
- $11.50
- Footnotes
- F2
SLGC
transaction
Derivative
Class B Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -25,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Sep 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences II Inc. or "CMLS II") and SomaLogic, Inc. ("SomaLogic"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis.
Footnote F2
Following the completion of the Business Combination, warrants to purchase Class A Common Stock become exercisable on October 1, 2021, the date that is 30 days after the closing of the Business Combination. The Conroy Family Foundation, Inc. (the "Conroy Foundation") is the record holder of the Class A Common Stock exercisable upon the issuance of warrants reported herein. Mr. Conroy has voting and investment discretion with respect to the Class A Common Stock held of record by the Conroy Foundation. As such, Mr. Conroy may be deemed to have or share beneficial ownership of the securities held directly by the Conroy Foundation. Mr. Conroy disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.